ML18025B269: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
Line 3: Line 3:
| issue date = 01/22/2018
| issue date = 01/22/2018
| title = Memo for 5-year Review of Regulatory Guide 8.26
| title = Memo for 5-year Review of Regulatory Guide 8.26
| author name = Boyce T H
| author name = Boyce T
| author affiliation = NRC/RES/DE/RGDB
| author affiliation = NRC/RES/DE/RGDB
| addressee name = Thomas B E
| addressee name = Thomas B
| addressee affiliation = NRC/RES/DE
| addressee affiliation = NRC/RES/DE
| docket =  
| docket =  

Revision as of 02:42, 18 June 2019

Memo for 5-year Review of Regulatory Guide 8.26
ML18025B269
Person / Time
Issue date: 01/22/2018
From: Boyce T
NRC/RES/DE/RGDB
To: Bernard Thomas
NRC/RES/DE
Karagiannis H
Shared Package
ML18024B347 List:
References
RG-8.026
Download: ML18025B269 (2)


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 22, 2018 MEMORANDUM TO: Brian E. Thomas, Director Division of Engineering Office of Nuclear Regulatory Research

FROM: Thomas H. Boyce, Chief /

RA/ Regulatory Guidance and Generic Issues Branch Division of Engineering Office of Nuclear Regulatory Research

SUBJECT:

RESULTS OF PERIODIC REVIEW OF REGULATORY GUIDE 8.26

This memorandum documents the U.S. Nuclear Regulatory Commission (NRC) periodic reviews of Regulatory Guide (RG) 8.26, Revision 0, "Applications of Bioassay for Fission and Activation Products." As discussed in Management Directive 6.6, "Regulatory Guides," the NRC staff reviews RGs periodically to ensure that the RGs continue to provide useful guidance.

Documentation of the NRC staff reviews is enclosed with a brief description listed below:

  • RG 8.26 has been reviewed with issues identified for future consideration. The staff will consider revising Revision 0 to RG 8.26 if more substantive changes to applicable standards are published, or if the staff finds that further guidance is needed in the implementation of bioassay for fission and activation products.

Enclosures:

Regulatory Guide Periodic Reviews CONTACTS: Casper Sun, RES/DSA/RPB 301-415-1646 Steve Garry, NRR/DRA/ARCB 301-415-2766

ML18024B347 OFFICE RES/DE/RGGIB RES/RSA/RPBNRR/DRA/ARCB NAME J. Parks R. Tadesse S. Garry DATE 12/ 18 /17 12/ 18 /17 12/ 17 /17 OFFICE NRR/DRA/ARCB RES/DE/RGGI B SUNSI Review RES/DE/RGGIB NAME K. Hsueh H. KaragiannisH. Karagiannis T. Boyce DATE 1/ 19 /18 1/ 19 /187 1/ 19 /18 1/ 22 /18